Drug profile

The FDA adverse-event record for Atropine Sulfate (Ophthalmic)

11 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Atropine Sulfate (Ophthalmic). See the species affected, top reactions, and outcomes below.

11
adverse-event reports
0.0%
death-coded share
Dog
most-reported species
3
Behavioural disorder NOS - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
11
Total Reports
0
Deaths Reported
0.0%
Death Rate

Active Ingredients

Atropine Sulfate (Ophthalmic)

Administration Routes

OphthalmicUnknown

Species Affected

Dog 11

Most Affected Breeds

Shih Tzu 3
Chihuahua 2
Bulldog - French 1
Pit Bull 1
Terrier - Boston 1
Pug 1
Dachshund (unspecified) 1
Bulldog - American 1

Most Reported Reactions

Behavioural disorder NOS 3
Corneal ulcer 3
Vomiting 2
Other abnormal test result NOS 2
Deafness 2
Scratching 2
Eye disorder NOS (for Photophobia see neurological) 2
Erythema (for urticaria see Immune SOC) 1
Pruritus 1
Emesis 1
Eye disorder NOS (for photophobia see 'neurological') 1
Itching 1

Outcome Breakdown

Recovered/Normal
4 (36.4%)
Outcome Unknown
4 (36.4%)
Ongoing
2 (18.2%)
Recovered with Sequela
1 (9.1%)

Atropine Sulfate (Ophthalmic) Adverse Event Insights

11 reports name Atropine Sulfate (Ophthalmic); 0 recorded a death outcome (0.0% of reported events, not a population-level mortality rate). Active ingredient: Atropine Sulfate (Ophthalmic). Administration routes: Ophthalmic, Unknown.

By species: Dog (11 reports). By breed: Shih Tzu (3), Chihuahua (2), Bulldog - French (1).

Leading clinical signs: Behavioural disorder NOS (3), Corneal ulcer (3), Vomiting (2), Other abnormal test result NOS (2). Outcome, 11 coded reports: Recovered/Normal leads at 36.4%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.